Peter Morgan Kash - Net Worth and Insider Trading

Peter Morgan Kash Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Morgan Kash owns 3 companies in total, including Capricor Therapeutics Inc (CAPR) , Keryx Biopharmaceuticals Inc (KERX) , and Healthcare Capital Corp (HCCCU) .

Click here to see the complete history of Peter Morgan Kash’s form 4 insider trades.

Insider Ownership Summary of Peter Morgan Kash

Ticker	Comapny	Transaction Date	Type of Owner
CAPR	Capricor Therapeutics Inc	2007-09-17	director
KERX	Keryx Biopharmaceuticals Inc	2004-06-11	director
HCCCU	Healthcare Capital Corp	2021-01-14	director

Peter Morgan Kash Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter Morgan Kash Ownership Network

Ownership Network List of Peter Morgan Kash

No Data

Ownership Network Relation of Peter Morgan Kash

Peter Morgan Kash Owned Company Details

What does Capricor Therapeutics Inc do?

Who are the key executives at Capricor Therapeutics Inc?

Peter Morgan Kash is the director of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and EVP & GENERAL COUNSEL Karen Krasney .

Capricor Therapeutics Inc (CAPR) Insider Trades Summary

Over the past 18 months, Peter Morgan Kash made no insider transaction in Capricor Therapeutics Inc (CAPR). Other recent insider transactions involving Capricor Therapeutics Inc (CAPR) include a net purchase of 2,798,507 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc (CAPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Capricor Therapeutics Inc (CAPR) were sold and 2,798,507 shares were bought by its insiders, resulting in a net purchase of 2,798,507 shares.

Capricor Therapeutics Inc (CAPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Capricor Therapeutics Inc Insider Transactions

No Available Data

What does Keryx Biopharmaceuticals Inc do?

Who are the key executives at Keryx Biopharmaceuticals Inc?

Peter Morgan Kash is the director of Keryx Biopharmaceuticals Inc. Other key executives at Keryx Biopharmaceuticals Inc include director & Interim CEO Jodie Pope Morrison , Chief Financial Officer Scott A Holmes , and 10 percent owner Baupost Group Gp, L.l.c. .

Keryx Biopharmaceuticals Inc (KERX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Keryx Biopharmaceuticals Inc (KERX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Keryx Biopharmaceuticals Inc (KERX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Keryx Biopharmaceuticals Inc (KERX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Keryx Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Healthcare Capital Corp do?

Who are the key executives at Healthcare Capital Corp?

Peter Morgan Kash is the director of Healthcare Capital Corp. Other key executives at Healthcare Capital Corp include director & 10 percent owner David Mark Milch , director & 10 percent owner Healthcare Capital Sponsor Llc , and director & Chief Executive Officer William Johns .

Healthcare Capital Corp (HCCCU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Healthcare Capital Corp (HCCCU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Healthcare Capital Corp (HCCCU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Healthcare Capital Corp (HCCCU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Healthcare Capital Corp Insider Transactions

No Available Data

Peter Morgan Kash Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Morgan Kash. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Peter Morgan Kash's mailing address is: New York Ny 10022.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.